Focused Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Focused Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-20	Closed	-$3K	–	760
2017 Q4	$3K	Buy	+20	New	+$2.35K	﹤0.01%	601
2016 Q1	–	Sell	-168	Closed	-$12K	–	733
2015 Q4	$12K	Hold	168	–	–	0.01%	384
2015 Q3	$15K	Hold	168	–	–	0.01%	340
2015 Q2	$21K	Hold	168	–	–	0.01%	308
2015 Q1	$15K	Hold	168	–	–	0.01%	368
2014 Q4	$11K	Hold	168	–	–	0.01%	411
2014 Q3	$14K	Buy	+168	New	+$14.9K	0.01%	385

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Focused Wealth Management's GWPH Position: Q1 2018 in Review

Focused Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2018, closing a stake of 20 shares — an estimated $3K sold.

Focused Wealth Management first reported a position in GWPH in Q3 2014 and held it in 7 quarters. The position peaked at $21K in Q2 2015. 191 funds tracked by Wall St. Rank hold GWPH as of Q1 2018.

Focused Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2018 after selling out during the quarter.
Focused Wealth Management sold 20 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2018, an estimated $3K.
Focused Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2014 and held it in 7 quarters.
Focused Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $21K in Q2 2015.
191 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2018.

Based on Focused Wealth Management's 13F filing for Q1 2018, filed 7 May 2018.